{"title":"Staphylococcal Functional Amyloids: Structure, Pathogenic Roles, Biofilm Fortification, and Inhibition Strategies.","authors":"Nikita Admane, Sumit Biswas","doi":"10.1021/acsinfecdis.5c00572","DOIUrl":null,"url":null,"abstract":"<p><p>Amyloid aggregates, which are hallmarks of various human diseases, show promising roles in almost all life forms. In the past few years, there has been a significant broadening of the diverse roles that bacterial functional amyloids play in nature, expanding the horizons of these fibrillar assemblies. Herein, we provide a review of the current understanding of staphylococcal functional amyloids, their multifaceted roles in pathogenesis, and strengthening biofilm-associated antibiotic resistance. This review aims to explore how staphylococcal biofilm strengthening amyloidogenic proteins and peptides, particularly derived from <i>Staphylococcus aureus</i> and <i>Staphylococcus epidermidis</i>, can act as dual-edged swords supporting pathogenesis in the planktonic stages and triggering infections in biofilms. We outline the different amyloid fibrillar species derived from these proteins/peptides and the molecules that have been discovered to target their amyloid transformation. This review also highlights how the noncanonical structural polymorphisms of these extracellular fibrillar amyloids are responsible for their functional diversity and discusses the techniques that are used recently for exploring staphylococcal amyloid structure assortment.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acsinfecdis.5c00572","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Amyloid aggregates, which are hallmarks of various human diseases, show promising roles in almost all life forms. In the past few years, there has been a significant broadening of the diverse roles that bacterial functional amyloids play in nature, expanding the horizons of these fibrillar assemblies. Herein, we provide a review of the current understanding of staphylococcal functional amyloids, their multifaceted roles in pathogenesis, and strengthening biofilm-associated antibiotic resistance. This review aims to explore how staphylococcal biofilm strengthening amyloidogenic proteins and peptides, particularly derived from Staphylococcus aureus and Staphylococcus epidermidis, can act as dual-edged swords supporting pathogenesis in the planktonic stages and triggering infections in biofilms. We outline the different amyloid fibrillar species derived from these proteins/peptides and the molecules that have been discovered to target their amyloid transformation. This review also highlights how the noncanonical structural polymorphisms of these extracellular fibrillar amyloids are responsible for their functional diversity and discusses the techniques that are used recently for exploring staphylococcal amyloid structure assortment.
期刊介绍:
ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to:
* Discovery and development of new antimicrobial agents — identified through target- or phenotypic-based approaches as well as compounds that induce synergy with antimicrobials.
* Characterization and validation of drug target or pathways — use of single target and genome-wide knockdown and knockouts, biochemical studies, structural biology, new technologies to facilitate characterization and prioritization of potential drug targets.
* Mechanism of drug resistance — fundamental research that advances our understanding of resistance; strategies to prevent resistance.
* Mechanisms of action — use of genetic, metabolomic, and activity- and affinity-based protein profiling to elucidate the mechanism of action of clinical and experimental antimicrobial agents.
* Host-pathogen interactions — tools for studying host-pathogen interactions, cellular biochemistry of hosts and pathogens, and molecular interactions of pathogens with host microbiota.
* Small molecule vaccine adjuvants for infectious disease.
* Viral and bacterial biochemistry and molecular biology.